On March 1, 2024, Crinetics Pharmaceuticals, Inc closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.49 USD | +2.25% | -0.79% | +41.91% |
05-10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
05-09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.91% | 3.89B | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Crinetics Pharmaceuticals, Inc. announced that it has received $350.000028 million in funding from a group of investors